News / Pakistan

Lilly's next-gen drug outperforms Ozempic in weight loss trial

Lilly’s next-gen drug outperforms Ozempic in weight loss trialEli Lilly’s experimental next-generation drug retatrutide achieved a greater therapeutic response of Novo Nordisk’s Ozempic on blood sugar control and produced greater than double the reduction in body weight in a study of...

Headline and summary provided via NewsData.io. The full article and its copyright belong to the original publisher.